Organic electroluminescent materials and devices

ABSTRACT

A compound of Formula X 
     
       
         
         
             
             
         
       
         
         
           
             wherein 
             ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; and at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W 1 —W 3  and ring B fused to ring N—W 4 —W 6 ; 
             W 1 , W 2 , W 3 , W 4 , W 5 , and W 6  are independently selected from CR 1  or N; 
             Z is selected from CR Z  or N; and Y is selected from a group consisting of C(R 2 ) 2 , B(R 2 ) 2 , Al(R 2 ) 2 , Si(R 2 ) 2 , and Ge(R 2 ) 2 . 
           
         
       
    
     An optoelectronic device selected from the group consisting of a photovoltaic device, a photodetector device, a photosensitive device, and an OLED, the optoelectronic device including an organic layer that comprises a compound of Formula X. A consumer product that includes the optoelectronic device.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. patent application Ser. No. 16/262,460 filed Jan. 30, 2019, which is incorporated herein by reference in its entirety.

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

This invention was made with government support under DE-SC0016450 and DE-EE0008244 awarded by the U.S. Department of Energy, and CBET1511757 awarded by the National Science Foundation.

PARTIES TO A JOINT RESEARCH AGREEMENT

The claimed invention was made by, on behalf of, and/or in connection with one or more of the following parties to a joint university corporation research agreement: Regents of the University of Michigan, Princeton University, University of Southern California, and the Universal Display Corporation. The agreement was in effect on and before the date the claimed invention was made, and the claimed invention was made as a result of activities undertaken within the scope of the agreement.

FIELD

The present invention relates to compounds for use as emissive materials, and the use of the emissive materials in optoelectronic devices, e.g., as organic light emitting diodes.

BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively, the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.

One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)₃, which has the following structure:

In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.

As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

SUMMARY

A compound of Formula X

wherein

ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

wherein at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W¹—W³ and ring B fused to ring N—W⁴—W⁶;

W¹, W², W³, W⁴, W⁵, and W⁶ are independently selected from CR¹ or N;

Z is selected from CR^(Z) or N;

Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂; wherein

R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, two R² join to form a cycloalkyl or heterocyclic ring;

wherein optionally, R¹ can join with R^(Z) to form a five-membered or six-membered, carbocyclic or heterocyclic ring, which is optionally substituted.

An optoelectronic device selected from the group consisting of a photovoltaic device, a photodetector device, a photosensitive device, and an OLED, the optoelectronic device including an organic layer that comprises a compound of Formula X. A consumer product that includes the optoelectronic device.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

DETAILED DESCRIPTION

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F₄-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2 .

Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2 . For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and organic vapor jet printing (OVJP). Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. A consumer product comprising an OLED that includes the compound of the present disclosure in the organic layer in the OLED is disclosed. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, a light therapy device, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.

The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

The terms “halo,” “halogen,” and “halide” are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.

The term “acyl” refers to a substituted carbonyl radical (C(O)—R_(s)).

The term “ester” refers to a substituted oxycarbonyl (—O—C(O)—R_(s) or —C(O)—O—R_(s)) radical.

The term “ether” refers to an —OR_(s) radical.

The terms “sulfanyl” or “thio-ether” are used interchangeably and refer to a —SR_(s) radical.

The term “sulfinyl” refers to a —S(O)—R_(s) radical.

The term “sulfonyl” refers to a —SO₂—R_(s) radical.

The term “phosphino” refers to a —P(R_(s))₃ radical, wherein each R_(s) can be same or different.

The term “silyl” refers to a —Si(R_(s))₃ radical, wherein each R_(s) can be same or different.

In each of the above, R_(s) can be hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combination thereof. Preferred R_(s) is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and combination thereof.

The term “alkyl” refers to and includes both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group is optionally substituted.

The term “cycloalkyl” refers to and includes monocyclic, polycyclic, and spiro alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl, adamantyl, and the like. Additionally, the cycloalkyl group is optionally substituted.

The terms “heteroalkyl” or “heterocycloalkyl” refer to an alkyl or a cycloalkyl radical, respectively, having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Additionally, the heteroalkyl or heterocycloalkyl group is optionally substituted.

The term “alkenyl” refers to and includes both straight and branched chain alkene radicals. Alkenyl groups are essentially alkyl groups that include at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl groups are essentially cycloalkyl groups that include at least one carbon-carbon double bond in the cycloalkyl ring. The term “heteroalkenyl” as used herein refers to an alkenyl radical having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl, cycloalkenyl, or heteroalkenyl group is optionally substituted.

The term “alkynyl” refers to and includes both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group is optionally substituted.

The terms “aralkyl” or “arylalkyl” are used interchangeably and refer to an alkyl group that is substituted with an aryl group. Additionally, the aralkyl group is optionally substituted.

The term “heterocyclic group” refers to and includes aromatic and non-aromatic cyclic radicals containing at least one heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Hetero-aromatic cyclic radicals may be used interchangeably with heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers/thio-ethers, such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and the like. Additionally, the heterocyclic group may be optionally substituted.

The term “aryl” refers to and includes both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group is optionally substituted.

The term “heteroaryl” refers to and includes both single-ring aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. The heteroatoms include, but are not limited to O, S, N, P, B, Si, and Se. In many instances, O, S, or N are the preferred heteroatoms. Hetero-single ring aromatic systems are preferably single rings with 5 or 6 ring atoms, and the ring can have from one to six heteroatoms. The hetero-polycyclic ring systems can have two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. The hetero-polycyclic aromatic ring systems can have from one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group is optionally substituted.

Of the aryl and heteroaryl groups listed above, the groups of triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole, and the respective aza-analogs of each thereof are of particular interest.

The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl, as used herein, are independently unsubstituted, or independently substituted, with one or more general substituents.

In many instances, the general substituents are selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, sulfanyl, and combinations thereof.

In yet other instances, the more preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

The terms “substituted” and “substitution” refer to a substituent other than H that is bonded to the relevant position, e.g., a carbon or nitrogen. For example, when R¹ represents mono-substitution, then one R¹ must be other than H (i.e., a substitution). Similarly, when R¹ represents di-substitution, then two of R¹ must be other than H. Similarly, when R¹ represents no substitution, R¹, for example, can be a hydrogen for available valencies of ring atoms, as in carbon atoms for benzene and the nitrogen atom in pyrrole, or simply represents nothing for ring atoms with fully filled valencies, e.g., the nitrogen atom in pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valencies in the ring atoms.

As used herein, “combinations thereof” indicates that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, an alkyl and deuterium can be combined to form a partial or fully deuterated alkyl group; a halogen and alkyl can be combined to form a halogenated alkyl substituent; and a halogen, alkyl, and aryl can be combined to form a halogenated arylalkyl. In one instance, the term substitution includes a combination of two to four of the listed groups. In another instance, the term substitution includes a combination of two to three groups. In yet another instance, the term substitution includes a combination of two groups. Preferred combinations of substituent groups are those that contain up to fifty atoms that are not hydrogen or deuterium, or those which include up to forty atoms that are not hydrogen or deuterium, or those that include up to thirty atoms that are not hydrogen or deuterium. In many instances, a preferred combination of substituent groups will include up to twenty atoms that are not hydrogen or deuterium.

The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

As used herein, “deuterium” refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. Pat. No. 8,557,400, Patent Pub. No. WO 2006/095951, and U.S. Pat. Application Pub. No. US 2011/0037057, which are hereby incorporated by reference in their entireties, describe the making of deuterium-substituted organometallic complexes. Further reference is made to Ming Yan, et al., Tetrahedron 2015, 71, 1425-30 and Atzrodt et al., Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65, which are incorporated by reference in their entireties, describe the deuteration of the methylene hydrogens in benzyl amines and efficient pathways to replace aromatic ring hydrogens with deuterium, respectively.

It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

A compound of Formula X

wherein

ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

wherein at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W¹—W³ and ring B fused to ring N—W⁴—W⁶;

W¹, W², W³, W⁴, W⁵, and W⁶ are independently selected from CR¹ or N;

Z is selected from CR^(Z) or N;

Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂; wherein

R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, two R² join to form a cycloalkyl or heterocyclic ring;

wherein optionally, R¹ can join with R^(Z) to form a five-membered or six-membered, carbocyclic or heterocyclic ring, which is optionally substituted.

In one embodiment, the compounds of Formula X will have groups R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. In another embodiment, the groups R^(Z) and each R¹ and R² is independently selected from the group consisting of H, D, F, —CN, —CF₃, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, heterocycle, and heteroaryl.

In one embodiment, the compounds of Formula X will have each W¹, W², W³, W⁴, W⁵, and W⁶ being CR¹. In another embodiment, the compounds of Formula X will have one of W¹, W², or W³ as N, and one of W⁴, W⁵, or W⁶ as N.

In one embodiment, the compounds of Formula X will have Y as B(R²)₂. In another embodiment, the compounds of Formula X will have Y as C(R²)₂.

Of particular interest are compounds of Formula X that have Z as N.

In one embodiment, the compounds of Formula X are selected from the group consisting of

wherein

X₁, X₂, X₃, X₄, X₅, X₆, X₇, and X₈ are independently selected from CR³ and N; wherein R³ is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent R³ join to form a ring.

Compounds of Formula X of particular interest will include Z being N, and Y being selected from B(R²)₂ or C(R²)₂. A more preferred embodiment of such compounds will have R² being independently selected from the group consisting of H, D, F, —CN, —CF₃, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, heterocycle, and heteroaryl.

In some of the above embodiments, at least one of X₁, X₂, X₃, X₄, X₅, X₆, X₇, and X₈ is N, and each distinct six-membered ring has no more than two nitrogen ring atoms.

In any one of the above embodied compounds of Formula, the compounds will include one of X₁, X₂, X₃, or X₄ as being N, and one of X₅, X₆, X₇, or X₈ as being N.

Compounds of Formula X of particular interest are selected from the group consisting of

wherein

R⁶, R⁷, and R⁸ are independently selected from the group consisting of H, D, F, —CN, —CF₃, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ alkenyl, C₅-C₆ cycloalkyl, C₆-C₁₀ aryl, C₆-C₁₀ aryloxy, C₅-C₆ heterocycle, and C₅-C₁₀ heteroaryl.

Additional compounds of interest are selected from Formula F1 or Formula F2

wherein

Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂;

X₁ to X₈, and X_(1′) to X_(8′), are independently selected from CR⁵ and N,

each R², R⁴, and R⁵ are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, two R² join to form a cycloalkyl or heterocyclic ring;

wherein optionally, two adjacent R⁴ join to form a ring, or two adjacent R⁵ join to form a ring.

The compounds of Formula F1 and Formula F2 emit in the red and infra-red region of the spectrum due to the extended conjugation of the compounds.

The invention is also directed to an optoelectronic device selected from the group consisting of a photovoltaic device, a photodetector device, a photosensitive device, and an OLED, the optoelectronic device including an organic layer that comprises a compound of Formula X

wherein

ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted;

wherein at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W¹—W³ and ring B fused to ring N—W⁴—W⁶;

W¹, W², W³, W⁴, W⁵, and W⁶ are independently selected from CR¹ or N;

Z is selected from CR^(Z) or N;

Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂; wherein

R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, two R² join to form a cycloalkyl or heterocyclic ring;

wherein optionally, R¹ can join with R^(Z) to form a five-membered or six-membered, carbocyclic or heterocyclic ring, which is optionally substituted.

As noted above, in one embodiment the optoelectronic device will include an organic layer with the compounds of Formula X that have groups R^(Z) and each R¹ and R² being independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. In another embodiment, the groups R^(Z) and each R¹ and R² is independently selected from the group consisting of H, D, F, —CN, —CF₃, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, aryloxy, heterocycle, and heteroaryl.

In another embodiment, the optoelectronic device will include an organic layer with compounds of Formula X that have each W¹, W², W³, W⁴, W⁵, and W⁶ being CR¹. In another embodiment, the compounds of Formula X will have one of W¹, W², or W³ as N, and one of W⁴, W⁵, or W⁶ as N.

Optoelectronic devices that include compounds of Formula X will tend to emit in the deep blue, blue, and green regions of the visible spectrum.

An optoelectronic device of particular interest is an OLED, wherein the organic layer is disposed between an anode and a cathode. The OLED can be used in such consumer products such as telephones and flat panel displays.

Of particular interest are OLED with an organic layer that further comprises a phosphorescent emissive dopant with a formula of M(L_(A))_(x)(L_(B))_(y)(L_(C))_(z) wherein L_(A), L_(B) and L_(C) are each a ligand; and wherein x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2; and x+y+z is the oxidation state of a metal M selected from the group consisting of Os, Ir, Cu, Pt, and Pd;

wherein L_(A), L_(B) and L_(C) are each independently selected from the group consisting of

wherein

each Y¹ to Y¹³ are independently selected from the group consisting of C and N;

Y′ is selected from the group consisting of BR_(e), NR_(e), PR_(e), O, S, Se, C═O, S═O, SO₂, CR_(e)R_(f), SiR_(e)R_(f), and G_(e)R_(e)R_(f);

R_(a), R_(b), R_(c), and R_(d) may independently represent from mono substitution to the maximum possible number of substitution, or no substitution;

each R_(a), R_(b), R_(c), R_(d), R_(e) and R_(f) is independently hydeogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent substituents of R_(a), R_(b), R_(c), or R_(d) join to form a ring or form a multidentate ligand.

In one embodiment, the phosphorescent emissive dopant will have a metal selected from Cu, Pt or Pd, and x is 1, y is 1, and z is 0, wherein ligand L_(A) and ligand L_(B) can be the same or different, and the ligands L_(A) and L_(B) connect to form a tetradentate ligand.

In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.

In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises a RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a lighting panel.

According to another aspect, an emissive region in an OLED (e.g., the organic layer described herein) is disclosed. The emissive region comprises a first compound as described herein. In some embodiments, the first compound in the emissive region is an emissive dopant or a non-emissive dopant. In some embodiments, the emissive dopant further comprises a host, wherein the host comprises at least one selected from the group consisting of metal complex, triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. In some embodiments, the emissive region further comprises a host, wherein the host is selected from the group consisting of:

and combinations thereof.

The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used maybe a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of C_(n)H_(2n+1), OC_(n)H_(2n+1), OAr₁, N(C_(n)H_(2n+1))₂, N(Ar₁)(Ar₂), CH═CH—C_(n)H_(2n+1), C≡C—C_(n)H_(2n+1), Ar₁, Ar₁—Ar₂, and C_(n)H_(2n)—Ar₁, or the host has no substitutions. In the preceding substituents n can range from 1 to 10; and Ar₁ and Ar₂ can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example a Zn containing inorganic material e.g. ZnS.

In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence; see, e.g., U.S. application Ser. No. 15/700,352, which is hereby incorporated by reference in its entirety), triplet-triplet annihilation, or combinations of these processes. In some embodiments, the emissive dopant can be a racemic mixture, or can be enriched in one enantiomer.

In some embodiments, the compound can be used as a fluorescent acceptor in an OLED where one or multiple layers in the OLED contains one or more sensitizer compounds. A sensitizer compound is a compound that can donate energy to an acceptor. The sensitizer may be a phosphorescent compound or emitter, a delayed fluorescent compound or emitter, or an exciplex. The acceptor compound is capable of receiving energy transfer from the sensitizer and then emits the energy as light or further transfers the energy to a final emitter. The compound's concentration may range from 0.001% to 100% by weight percentage or from 0.001% to 100% by volume percentage. The compound may be in the same layer as the sensitizer or in one or more different layers. In some embodiments, the emission may arise from any or a combination of the sensitizer, the acceptor, and the final emitter.

According to another aspect, a formulation comprising the compound described herein is also disclosed.

The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.

In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, electron blocking material, hole blocking material, and an electron transport material, disclosed herein.

Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.

Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047, and US2012146012.

HIL/HTL:

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO_(x); a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:

Each of Ar¹ to Ar⁹ is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, A¹ to Ar⁹ is independently selected from the group consisting of:

wherein k is an integer from 1 to 20; X¹⁰¹ to X¹⁰⁸ is C (including CH) or N; Z¹⁰¹ is NAr¹, O, or S; Ar¹ has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

wherein Met is a metal, which can have an atomic weight greater than 40; (Y¹⁰¹-Y¹⁰²) is a bidentate ligand, Y¹⁰¹ and Y¹⁰² are independently selected from C, N, O, P, and S; L¹⁰¹ is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, (Y¹⁰¹-Y¹⁰²) is a 2-phenylpyridine derivative. In another aspect, (Y¹⁰¹-Y¹⁰²) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc⁺/Fc couple less than about 0.6 V.

Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.

EBL:

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

Host:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.

Examples of metal complexes used as host are preferred to have the following general formula:

wherein Met is a metal; (Y¹⁰³-Y¹⁰⁴) is a bidentate ligand, Y¹⁰³ and Y¹⁰⁴ are independently selected from C, N, O, P, and S; L¹⁰¹ is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, the metal complexes are:

wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y¹⁰³-Y¹⁰⁴) is a carbene ligand.

Examples of other organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, the host compound contains at least one of the following groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20. X¹⁰¹ to X¹⁰⁸ are independently selected from C (including CH) or N. Z¹⁰¹ and Z¹⁰² are independently selected from NR¹⁰¹, O, or S.

Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472, US20170263869,

Additional Emitters:

One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.

HBL:

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.

In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

wherein k is an integer from 1 to 20; L¹⁰¹ is an another ligand, k′ is an integer from 1 to 3. ETL:

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar¹ to Ar³ has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X¹⁰¹ to X¹⁰⁸ is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:

wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L¹⁰¹ is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,

Charge Generation Layer (CGL)

In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.

EXPERIMENTAL

1,2-bis(4-(pyridin-4-yl)phenyl)-1H-phenanthro[9,10-d]imidazole (I6): A mixture of phenanthrene-9,10-dione (2.50 g, 12.01 mmol), 4-(pyridin-4-yl)aniline (2.45 g 14.41 mmol), 4-(pyridin-4-yl)benzaldehyde (2.20 g, 12.01 mmol) and ammonium acetate (1.85 g, 24.01 mmol) in glacial acetic acid (80 mL) was refluxed for 3 h. The precipitate was filtered and washed with aqueous NaOH deionized water. The residue is dried and sublimed at 270° C. and 1.2×10⁻⁶ torr to give pure product. White solid (4.30 g, 8.20 mmol, 68%).

Synthesis of aD: (a) 2,2′-dipyridylamine (aD ligand): A reported procedure was followed (cite); bis(2-diphenylphosphinophenyl) ether (498.99 mg, 926.51 μmol), 2-bromopyridine (3.66, 23.16 mmol), 2-aminopyridine (2.18 g, 23.16 mmol) and t-BuONa (3.12 g, 32.43 mmol) were purged with nitrogen gas in a re-sealable shlenk flask where a degassed dry toluene is cannula transferred. Pd(OAc)₂ catalyst was added to the air free flask and refluxed in a 110° C. oil bath for 24 hours. The reaction mixture is cooled to room temperature and diluted with THF and ethyl ether. The solid precipitate was filtered, concentrated, and purified via silica gel column chromatography (2% MeOH/CH₂Cl₂). An alternative route is to purchase the commercially available 2,2′-dipyridylamine.

(b) aza-DIPYR (aD): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A solution of the 2,2′-dipyridylamine ligand (300 mg, 1.75 mmol) in dry 1,2-dichloroethane was prepared in an N2-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux, at which time 2.0 eq. boron trifluoride diethyl etherate (497.40 mg, 3.50 mmol) were added dropwise. The solution was stirred for 2 hours at reflux, then cooled to room temperature and treated with 5 eq. N,N diisopropylethylamine (1.53 mL, 8.70 mmol). The solution was washed with water and the aqueous layer was separated and extracted three times with DCM. The total organic extractions were filtered, and reduced concentrated by rotary evaporation. The products were purified by silica gel flash chromatography with the eluent 50% dichloromethane in hexanes.

(a) 2,2′-diquinolylamine (α-aD ligand): A reported procedure was followed (cite); bis(2-diphenylphosphinophenyl) ether (395.03 mg, 733.48 μmol), 2-bromoquinoline (3.00 g, 18.34 mmol), 2-aminoquinoline (2.78 g, 19.25 mmol) and t-BuONa (2.47 g, 25.67 mmol) were purged with nitrogen gas in a re-sealable shlenk flask where degassed dry toluene is cannula transferred. Pd(OAc)₂ (164.67, 733.48 μmol) catalyst was added to the air free flask and refluxed in a 110° C. oil bath for 24 hours. The reaction mixture is cooled to room temperature and diluted with THF and ethyl ether. The solid precipitate was filtered, concentrated, and purified via silica gel column chromatography (2% MeOH/CH₂Cl₂). A white solid is isolated upon purification (40-80% yield).

(b) α-azaDIPYR (α-aD): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A 15 mM solution of 2,2′-diquinolylamine in dry 1,2-dichloroethane was prepared in an N₂-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux, at which time 2.0 eq. boron trifluoride diethyl etherate were added dropwise. The solution was stirred for 2 hours at reflux, then cooled to room temperature and treated with 5 eq. N,N diisopropylethylamine, causing the precipitate to dissolve. The solution was washed with water and the aqueous layer was separated and extracted three times with dichloromethane. The organic layers were combined, dried over sodium sulfate, filtered, and reduced concentrated by rotary evaporation. The products were purified by silica gel flash chromatography with the eluent 80% 2% MeOH/CH₂Cl₂ solvent mixture in hexanes. For further purification, the material was sublimed. 1H).

6-isopropylquinoline (1a). 4-isopropylaniline (20 g, 0.147 mole), nitrobenzene (9.86 ml, 0.096 mole), Glycerol (55.85 g, 0.606 mole), and FeSO₄.7H₂O (5.14 g, 18.49 mole) were added to a three-neck round bottom flask. While the flask was kept in an ice bath, H₂SO₄ (25 ml, 0.473 mole) was added slowly to the reaction mixture. After the addition was completed, the ice bath was removed followed by refluxing the mixture for 20 h under inert conditions. After cooling to room temperature, the pH of the solution was adjusted to pH 7 with 50% NaOH aq. Then, solution was extracted with diethyl ether. After the extraction, MgSO₄ was used as a drying agent. Filtration followed by evaporation to give a brown liquid. The product was isolated by reduced pressure distillation to yield the desired light-yellow liquid (yield 20%).

6-isopropylquinoline-1-oxide (2a). Compound (1a) (10.2 g, 0.059 mole) was dissolved in one-neck round bottom flask with CH₂Cl₂ (50 ml). M-chloroperoxybenzoic acid (m-CPBA) (12.33 g, 0.071 mole) was added slowly the stirred solution at room temperature. The reaction was stirred overnight. Next, saturated NaHCO₃ aq solution was added to stirring solution until no CO₂ gas bubbles were observed anymore. Then, pH was adjusted to 10 with NaOH aq solution and extracted with CH₂Cl₂ 50 ml three times. The solution was dried over MgSO₄. The solvent was removed under reduced pressure. The crude product was then purified by silica gel column chromatography (2% Methanol/CH₂Cl₂). White pale-yellow solid was afforded at 60% yield.

6-isopropylquinoline-2-amine (3a). To a round bottom flask, compound (2a) (2.55 g, 0.013 mole) and 30 ml of trifluorotoluene (7.16 ml, 0.068 mole) were mixed in 20 ml of chloroform. After compound (2a) was dissolved, the mixture was cooled to 0° C. with an ice bath. T-butylamine (7.16 ml, 0.068 mole) was added slowly followed by Ts₂O (8.89 g, 0.027 mole). The reaction was left to stir for two hours. If the reaction were not completed, portions of t-butylamine (0.6 equiv. to 4.0 equiv.) and Ts₂O (0.3 equiv. to 2.3 equiv.) would be added until the reaction is completed. The reaction was then treated with 25 ml TFA at 70° C. for overnight under inert atmosphere. After that, most of the solvents were removed under reduced pressure and them the concentrated oil residue was diluted with CH₂Cl₂ and quenched with 50% of aq solution of NaOH to pH 10. The solution was extracted with CH₂Cl₂ three times, dried over MgSO₄, and removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (2% Methanol/CH₂Cl₂). The desired white solid was obtained at 70%.

2-bromo-6-isopropylquinoline (4a). To a round bottom flask cooled to 5° C. with an ice bath, benzoyl chloride (2.33 ml, 0.02 mol) was added slowly to the vigorously stirred mixture of compound (2a) (2.5 g, 0.0133 mol), sodium hydroxide (1 g, 0.025 mol) in water (12 ml) and CH₂Cl₂ (10 ml). After the addition is complete, the reaction mixture was left to stir for few hours. Then, the mixture was extracted from CH₂Cl₂. The combined organic layer was dried over MgSO₄. Solvent was removed under reduced pressure to obtain a white solid product. After that, the solid was mixed with POBr₃ (2.2 g, 0.007 mol) in dry toluene (20 ml) under inert atmosphere, heated to reflux overnight. After cooling to room temperature, the mixture was poured on ice, washed with saturated NaHCO₃ and extracted with CH₂Cl₂ several times. The solvent was removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (50% Hexane/CH₂Cl₂). The desired white solid was obtained at 40%.

Bis(6-isopropylquinoline-2-yl)amine (5a). Compound (3a) (2.23 g, 0.012 mol) and compound (4a) (3 g, 0.012 mol) were mixed with bis(2-diphenylphosphinophenyl)ether (0.246 g, 4% mmol), t-BuONa (1.54 g, 0.016 mol), and Pd(OAc)₂ (0.1 g, 4% mmol) in a three-neck round bottom flask. The flask was subjected to three cycles of evacuation-backfilling with N₂. Dry toluene purged with N₂ was transferred to the reaction mixture using a cannula. The reaction was refluxed for 48 h at 110° C. under inert atmosphere. After that, the mixture was cooled to room temperature, extracted from CH₂Cl₂, dried over MgSO₄, and solvent removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (2% Methanol/CH₂Cl₂). The desired white solid was obtained at 50%.

(α-aID). Compound (5a) (1 g, 0.0028 mol) was dissolved in dry toluene under N₂ in a three-neck round bottom flask. DIEA (1.47 ml, 0.008 mol) was slowly injected to the solution. After 30 min stirring, BF₃OEt₂ (1.39 ml, 0.0011 mol) was slowly added dropwise to the solution. The reaction was then left to reflux overnight. After cooling to room temperature, saturated solution of NaHCO₃ aq was added to the reaction mixture, followed by extraction from CH₂Cl₂. The combined organic layers were dried over MgSO₄, and solvent removed under reduced pressure. The crude product was purified by silica gel chromatography (50% Hexane/Ethyl acetate) to afford a yellow solid. The desired product was further sublimed at 190° C. under 1.2×10⁻⁶ torr.

2,2′-di-5-methoxyquinolylamine (α-5OD ligand): bis(2-diphenylphosphinophenyl) ether (43 mg, 80 μmol), 2-bromo-5-methoxyquinoline (500 mg, 2.1 mmol), 2-amino-5-methoxyquinoline (365 mg, 2.1 mmol) and t-BuONa (269 mg, 2.8 mmol), and Pd(OAc)₂ (17.96 mg, 80 μmol) catalyst were added to a three-neck round bottom flask. The air free flask and refluxed in a 110° C. oil bath for 48 hours. The flask was subjected to three cycles of evacuation-backfilling with N₂. Dry toluene purged with N₂ was transferred to the reaction mixture using a cannula. The reaction was refluxed for 48 h at 110° C. under inert atmosphere. After that, the mixture was cooled to room temperature, extracted from CH₂Cl₂, dried over MgSO₄, and solvent removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (2% Methanol/CH₂Cl₂).

(α-5OD). In a three-neck round bottom flask, the ligand, 2,2′-di-5-methoxyquinolylamine (α-5OD ligand) (500 mg, 1.51 mmol) was dissolved in dry toluene under N₂. DIEA (0.79 ml, 4.53 mmol) was slowly injected to the solution. After 30 min of stirring, BF₃OEt₂ (0.745 ml, 6.04 mmol) was slowly added dropwise to the solution. The reaction was then left to reflux overnight. After cooling to room temperature, saturated solution of NaHCO₃ aq was added to the reaction mixture, followed by extraction from CH₂Cl₂. The combined organic layers were dried over MgSO₄, and solvent removed under reduced pressure. The crude product was purified by silica gel chromatography (2% Methanol/CH₂Cl₂) to afford a yellow solid. The desired product was further sublimed at 200° C. under 1.2×10⁻⁶ torr.

5-methoxy-N-(quinolin-2-yl)quinolin-2-amine (αα-OD ligand): bis(2-diphenylphosphinophenyl) ether (17.23 mg, 32 μmol), 2-bromo-5-methoxyquinoline (200 mg, 0.84 mmol), 2-aminoquinoline (121 mg, 0.84 mmol) and t-BuONa (107.64 mg, 1.12 mmol), and Pd(OAc)₂ (7.18 mg, 32 μmol) catalyst were added to a three-neck round bottom flask. The air free flask and refluxed in a 110° C. oil bath for 48 hours. The flask was subjected to three cycles of evacuation-backfilling with N₂. Dry toluene purged with N₂ was transferred to the reaction mixture using a cannula. The reaction was refluxed for 48 h at 110° C. under inert atmosphere. After that, the mixture was cooled to room temperature, extracted from CH₂Cl₂, dried over MgSO₄, and solvent removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (2% Methanol/CH₂Cl₂).

(αα-OD). In a three-neck round bottom flask, the ligand, 5-methoxy-N-(quinolin-2-yl)quinolin-2-amine (α-5OD ligand) (500 mg, 1.51 mmol) was dissolved in dry toluene under N₂. DIEA (0.79 ml, 4.53 mmol) was slowly injected to the solution. After 30 min of stirring, BF₃OEt₂ (0.745 ml, 6.04 mmol) was slowly added dropwise to the solution. The reaction was then left to reflux overnight. After cooling to room temperature, saturated solution of NaHCO₃ aq was added to the reaction mixture, followed by extraction from CH₂Cl₂. The combined organic layers were dried over MgSO₄, and solvent removed under reduced pressure. The crude product was purified by silica gel chromatography (2% Methanol/CH₂Cl₂) to afford a yellow solid. The desired product was further sublimed at 200° C. under 1.2×10⁻⁶ torr.

N-(isoquinolin-1-yl)-5-methoxyquinolin-2-amine (α□-OD ligand): bis(2-diphenylphosphinophenyl) ether (23.56 mg, 43.74 μmol), 2-amino-5-methoxyquinoline (200 mg, 1.15 mmol), 1-chloroisoquinoline (187.83 mg, 1.15 mmol) and t-BuONa (147.12 mg, 1.53 mmol), and Pd(OAc)₂ (9.82 mg, 43.74 μmol) catalyst were added to a three-neck round bottom flask. The air free flask and refluxed in a 110° C. oil bath for 48 hours. The flask was subjected to three cycles of evacuation-backfilling with N₂. Dry toluene purged with N₂ was transferred to the reaction mixture using a cannula. The reaction was refluxed for 48 h at 110° C. under inert atmosphere. After that, the mixture was cooled to room temperature, extracted from CH₂Cl₂, dried over MgSO₄, and solvent removed under reduced pressure. The crude product was then purified using a silica gel column chromatography (2% Methanol/CH₂Cl₂).

(α□-OD). In a three-neck round bottom flask, the ligand, N-(isoquinolin-1-yl)-5-methoxyquinolin-2-amine (α□-OD ligand) (300 mg, 1.0 mmol) was dissolved in dry toluene under N₂. DIEA (0.52 ml, 2.99 mmol) was slowly injected to the solution. After 30 min of stirring, BF₃OEt₂ (0.491 ml, 3.98 mmol) was slowly added dropwise to the solution. The reaction was then left to reflux overnight. After cooling to room temperature, saturated solution of NaHCO₃ aq was added to the reaction mixture, followed by extraction from CH₂Cl₂. The combined organic layers were dried over MgSO₄, and solvent removed under reduced pressure. The crude product was purified by silica gel chromatography (2% Methanol/CH₂Cl₂) to afford a yellow solid. The desired product was further sublimed at 200° C. under 1.2×10⁻⁶ torr.

azaDIPYR (aD): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A solution of the 2,2′-dipyridylamine ligand (300 mg, 1.75 mmol) in dry 1,2-dichloroethane was prepared in an N2-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux, at which time 2.0 eq. boron trifluoride diethyl etherate (497.40 mg, 3.50 mmol) were added dropwise. The solution was stirred for 2 hours at reflux, then cooled to room temperature and treated with 5 eq. N,N diisopropylethylamine (1.53 mL, 8.70 mmol). The solution was washed with water and the aqueous layer was separated and extracted three times with dichloromethane. The organic layers were combined, dried over sodium sulfate, filtered, and reduced concentrated by rotary evaporation. The products were purified by silica gel flash chromatography with the eluent 50% dichloromethane in hexanes. (b) azaDIPYRBT₂ (aDBT₂): A solution of aD (528 mg, 2.27 mmol) in dry toluene or dry THF was purged with nitrogen gas in a sealed round bottom flask equipped with a stir bar. o-Tolylmagnesium bromide (2.0M, 9.06 mL, 9.06 mmol) was added dropwise at 25° C. and allowed to stir for 12 hours. Additional o-Tolylmagnesium bromide was added and allowed to stir for 3 hours. The reaction was quenched with water and extracted three times with 100 mL of ethylacetate. The extracted organic fraction was dried using sodium sulfate, concentrated using a rotary evaporation. The product was purified by silica gel flash chromatography with the eluent 80% ethylacetate in hexanes.

(a) azaDIPYRBPh₂ (aDBPh₂): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A solution of the 2,2′-dipyridylamine ligand (800 mg, 4.67 mmol) and diphenylboronic anhydride (1.62 g, 4.67 mmol) in dry 1,2-dichloroethane was prepared in an N₂-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux for 16 hours. The solution was washed with water and the aqueous layer was separated and extracted three times with dichloromethane. The organic layers were combined, dried over sodium sulfate, filtered, and reduced concentrated by rotary evaporation. The product was purified by silica gel flash chromatography with 100% ethylacetate then 100% acetone.

(a) azaCARDIPYR (α-CarD): A reported procedure was followed (cite); 2,2′-dipyridylamine (0.94 mg, 9.99 mmol) and diiodomethane (4.01 g, 14.98 mmol) was refluxed in dry acetonitrile for 28 hours under nitrogen. The reaction mixture was cooled to room temperature and allowed to sit in air for 2 hours. A solid precipitated out of solution and was isolated as the pure product after filtering and rinsing with methanol.

(a) α-azaCARDIPYR (α-aCarD): A reported procedure was followed (cite); 2,2′-diquinolylamine (1.00 g, 6.94) and diiodomethane (2.79, 10.40 mmol) was refluxed in dry acetonitrile for 28 hours under nitrogen. The reaction mixture was cooled to room temperature and allowed to sit in air for 2 hours. A solid precipitated out of solution and was isolated as the pure product after filtering and rinsing with methanol.

(a) 2,2′-diquinolylamine (α-aD ligand): A reported procedure was followed (cite); bis(2-diphenylphosphinophenyl) ether (395.03 mg, 733.48 μmol), 2-bromoquinoline (3.00 g, 18.34 mmol), 2-aminoquinoline (2.78 g, 19.25 mmol) and t-BuONa (2.47 g, 25.67 mmol) were purged with nitrogen gas in a re-sealable shlenk flask where a degassed dry toluene is cannula transferred. Pd(OAc)₂ (164.67, 733.48 μmol) catalyst was added to the air free flask and refluxed in a 110° C. oil bath for 24 hours. The reaction mixture is cooled to room temperature and diluted with THF and ethyl ether. The solid precipitate was filtered, concentrated, and purified via silica gel column chromatography (2% MeOH/CH₂Cl₂). A white solid is isolated upon purification (40-80% yield).

(b) α-azaDIPYRBT₂ (α-aDBT₂): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A 15 mM solution of the 2,2′-diquinolylamine ligand and diphenylboronic anhydride in dry 1,2-dichloroethane was prepared in an N₂-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux for 16 hours. The solution was washed with water and the aqueous layer was separated and extracted three times with dichloromethane. The organic layers were combined, dried over sodium sulfate, filtered, and reduced concentrated by rotary evaporation. The product was purified by silica gel flash chromatography with 100% ethylacetate then 100% acetone.

a) 2,2′-diquinolylamine (α-aD ligand): A reported procedure was followed (cite); bis(2-diphenylphosphinophenyl) ether (395.03 mg, 733.48 μmol), 2-bromoquinoline (3.00 g, 18.34 mmol), 2-aminoquinoline (2.78 g, 19.25 mmol) and t-BuONa (2.47 g, 25.67 mmol) were purged with nitrogen gas in a re-sealable shlenk flask where a degassed dry toluene is cannula transferred. Pd(OAc)₂ (164.67, 733.48 μmol) catalyst was added to the air free flask and refluxed in a 110° C. oil bath for 24 hours. The reaction mixture is cooled to room temperature and diluted with THF and ethyl ether. The solid precipitate was filtered, concentrated, and purified via silica gel column chromatography (2% MeOH/CH₂Cl₂). A white solid is isolated upon purification (40-80% yield).

(b) α-azaDIPYR (α-aD): All reagents were purchased from Sigma Aldrich and used without purification. Anhydrous 1,2 dichloroethane was purchased from EMD Millipore. A 15 mM solution of 2,2′-diquinolylamine in dry 1,2-dichloroethane was prepared in an N₂-purged schlenk flask equipped with a magnetic stir bar and fitted with a reflux condenser. The flask was submerged in a preheated oil bath and brought to reflux, at which time 2.0 eq. boron trifluoride diethyl etherate were added dropwise. The solution was stirred for 2 hours at reflux, then cooled to room temperature and treated with 5 eq. N,N diisopropylethylamine, causing the precipitate to dissolve. The solution was washed with water and the aqueous layer was separated and extracted three times with dichloromethane. The organic layers were combined, dried over sodium sulfate, filtered, and reduced concentrated by rotary evaporation. The products were purified by silica gel flash chromatography with the eluent 2% MeOH/CH₂Cl₂ solvent mixture in hexanes.

(c) α-azaDIPYRBT₂ (α-aDBT₂): A solution of α-aD (528 mg, 1.59 mmol) in dry toluene or dry THF was purged with nitrogen gas in a sealed round bottom flask equipped with a stir bar. o-Tolylmagnesium bromide (2.0M, 3.18 mL, 6.36 mmol) was added dropwise at 25° C. and allowed to stir for 12 hours. Additional o-Tolylmagnesium bromide was added and allowed to stir for 3 hours. The reaction was quenched with water and extracted three times with 100 mL of ethylacetate. The extracted organic fraction was dried using sodium sulfate, concentrated using a rotary evaporation. The product was purified by silica gel flash chromatography with the eluent 70% ethylacetate in hexanes.

It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting. 

We claim:
 1. An optoelectronic device selected from the group consisting of a photovoltaic device, a photodetector device, a photosensitive device, and an OLED, the optoelectronic device including an organic layer that comprises a compound of Formula X; wherein the compound of Formula X is a fluorescent acceptor; and wherein the optoelectronic device further comprises a phosphorescent sensitizer compound;

wherein ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; wherein at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W¹—W³ and ring B fused to ring N—W⁴—W⁶; wherein at least one of ring A or ring B is a 6-membered heteroaryl ring; W¹, W², W³, W⁴, W⁵, and W⁶ are independently selected from CR¹ or N; Z is selected from CR^(Z) or N; Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂; wherein R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, or optionally, two R² join to form a cycloalkyl or heterocyclic ring; wherein optionally, R¹ can join with R² to form a five-membered or six-membered, carbocyclic or heterocyclic ring, which is optionally substituted.
 2. The OLED of claim 1, wherein the organic layer is disposed between an anode and a cathode.
 3. The OLED of claim 1, wherein the phosphorescent sensitizer compound forms an exciplex.
 4. The OLED of claim 1, wherein the phosphorescent sensitizer compound and the compound of Formula X are in the same layer.
 5. The OLED of claim 1, wherein the phosphorescent sensitizer compound and the compound of Formula X are in different layers.
 6. The OLED of claim 1, wherein the compound of Formula X has a concentration of from about 0.001% to about 100% by weight percentage or volume percentage.
 7. The OLED of claim 1, wherein the organic layer further comprises a host material, wherein the host material comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
 8. The OLED of claim 1, wherein the organic layer further comprises a host material selected from the group consisting of

and combinations thereof.
 9. The OLED of claim 1, wherein the organic layer further comprises a phosphorescent emissive dopant with a formula of M(L_(A))_(x)(L_(B))_(y)(L_(C))_(z) wherein L_(A), L_(B) and L_(C) are each a ligand; and wherein x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2; and x+y+z is the oxidation state of a metal M selected from the group consisting of Os, Ir, Cu, Pt, and Pd; wherein L_(A), L_(B) and L_(C) are each independently selected from the group consisting of

wherein each Y¹ to Y¹³ are independently selected from the group consisting of C and N; Y′ is selected from the group consisting of B R_(e), N R_(e), P R_(e), O, S, Se, C═O, S═O, SO₂, CR_(e)R_(f), SiR_(e)R_(f), and GeR_(e)R_(f), R_(a), R_(b), R_(c), and R_(d) may independently represent from mono substitution to the maximum possible number of substitution, or no substitution; each R_(a), R_(b), R_(c), R_(d), R_(e) and R_(f) is independently hydeogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent substituents of R_(a), R_(b), R_(c), or R_(d) join to form a ring or form a multidentate ligand.
 10. The OLED of claim 9, wherein the metal is selected from Cu, Pt, or Pd, and x is 1, y is 1, and z is 0, wherein ligand L_(A) and ligand L_(B) can be the same or different, and the ligands L_(A) and L_(B) connect to form a tetradentate ligand.
 11. The OLED of claim 1, wherein the phosphorescent sensitizer and the fluorescent acceptor are in different layers.
 12. A consumer product comprising an optoelectronic device comprising an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound of Formula X; wherein the compound of Formula X is a fluorescent acceptor; and wherein the optoelectronic device further comprises one or more phosphorescent sensitizer compounds;

wherein ring A is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; ring B is absent, or present and selected from a 5-membered or 6-membered, carbocyclic or heterocyclic ring, which is optionally substituted; wherein at least one of ring A or ring B is present, and the hash line represents ring A fused to ring N—W¹—W³ and ring B fused to ring N—W⁴—W⁶; wherein at least one of ring A or ring B is a 6-membered heteroaryl ring; W¹, W², W³, W⁴, W⁵, and W⁶ are independently selected from CR¹ or N; Z is selected from CR^(Z) or N; Y is selected from a group consisting of C(R²)₂, B(R²)₂, Al(R²)₂, Si(R²)₂, and Ge(R²)₂; wherein R^(Z) and each R¹ and R² are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, two R² join to form a cycloalkyl or heterocyclic ring; wherein optionally, R¹ can join with R^(Z) to form a five-membered or six-membered, carbocyclic or heterocyclic ring, which is optionally substituted; wherein the consumer product is selected from the group consisting of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, a light therapy device, and a sign. 